Summit Therapeutics (SMMT) stock received a new buy rating from Truist based on its deal-forming prospects in oncology. Read ...
Sana Biotechnology, Inc. shares surge as a breakthrough in diabetes therapy sparks investor interest. Click for my updated ...
Stocks are adjusting to yield curve normalization, not inflation fears. Job openings and ISM Services PMI rise suggest ...
Fagron (ARSUF) has refocused its M&A strategy, regaining market trust despite recent FDA issues. Read why I think the stock ...
The key pillar of my bull thesis is the company's ability to complete the $1.66 billion loan from the Department of Energy.
BUI gets positive ratings, DNP CEFs faces strong sell signals. Find out how a 12% distribution hike affects their current ...
Palantir Technologies Inc. stock is in a technical bear market, down 20% from its all-time high. Explore more details here.
GSK (GSK) stock is in focus as the company is nearing a $1B deal to acquire IDRx, a private biotech focused on a rare ...
US corporate bankruptcy filings hit a 14-year high in 2024 as filings continued at a steady clip in December 2024 and ...
The U.S. Treasury 10-year yield could trend toward 5% in 2025, supported by a combination of historical averages and a ...
US small-cap equities are at a critical juncture. Valuation gap between small and large-cap stocks grown exponentially wide ...
Luminar Technologies has strong growth potential with partnerships like Volvo and Nvidia, but faces financial challenges and ...